Vbi Vaccines Inc CS (VBIV)

$0.52 0.00 (0.00%)

16:00 EST VBIV Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jul 13, 2022

Good morning, investors! We're starting off the day with a breakdown of the biggest pre-market stock movers for Wednesday!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

VBIV Stock Is Shooting Higher on Big FDA Vaccine Approval News

7 Penny Stocks Waiting on the FDA for Rocket Fuel

Volume:

Previous Close -

Market Cap 134.66M

PE Ratio -7.45

EPS -0.07

Volume (Avg. Vol.) 7,661

Day's Range -

52-Week Range $0.45 - $2.75

Dividend & Yield N/A (N/A)

VBIV Stock Predictions, Articles, and Vbi Vaccines Inc CS News

From InvestorPlace
From the Web

8 Biotech Penny Stocks for Investors to Watch

By Thomas Niel, InvestorPlace Contributor Mar 10, 2021

Low-priced biotechs have sold off recently, but there could still be potential in these picks. Here are eight penny stocks to consider.

8 Penny Stocks to Avoid in 2021

By Thomas Niel, InvestorPlace Contributor Jan 11, 2021

With risk-return not in your favor, steer clear of these 8 penny stocks, all of which could see big declines as the new year unfolds. Chesapeake Energy (OTCMKTS:CHKAQ) Genius Brands (NASDAQ:GNUS) Hertz Global Holdings (OTCMKTS:HTZGQ) Remark Holdings (NASDAQ:MARK) Ocugen (NASDAQ:OCGN) StoneMor (NYSE:STON) VBI Vaccines (NASDAQ:VBIV) XspresSpa (NASDAQ:XSPA)

7 Short-Term Stocks to Make a Quick Buck

By Josh Enomoto, InvestorPlace Contributor Oct 16, 2020

It wasn’t just toilet paper that was in demand when Covid-19 hit us as short-term stocks flew through the roof. But with a second wave upon us, this narrative looks very compelling.

While Risks Remain, VBI Vaccines Stock Is a Buy at Today’s Prices

By Thomas Niel, InvestorPlace Contributor Feb 5, 2020

Sci-B-Vac's success will make or break VBIV stock. But the shares' recent pullback may have created a great buying opportunity.

5 Stocks Under $5 With Colossal Growth Prospects

By Maya Sasson, Writer, TipRanks Jan 31, 2020

While some argue you get what you pay for, others say that stocks trading at low levels can represent compelling opportunities.

Is It Time to Go Long on VBIV Stock?

By Chris Markoch, InvestorPlace Contributor Jan 30, 2020

As a speculative pharmaceutical investment, VBIV stock is not for the faint of heart. However, the underlying business suggests some rationale for longer-term optimism.